14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
×
Home
/
Stock Analysis
/
Compare Terminal
/
ELIL vs TBXU
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ELIL vs TBXU: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
TBXU Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)
TBXU Overall Winner
6-Pillar Tally: ELIL 0 – 0 TBXU (6 Tie)
Matrix Metrics: ELIL 0 – 3 TBXU
As of Nov 20, 2026, Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is the stronger overall head-to-head candidate over Direxion Daily LLY Bull 2X Shares (ELIL) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ELIL carries a Unified Composite Score of 42.5/100 (HOLD) at $36.41 (N/M Forward P/E, N/A operating margin), whereas TBXU carries 48.6/100 (HOLD) at $44.26 (N/M Forward P/E, N/A operating margin).
ELIL
NASDAQ
Direxion Daily LLY Bull 2X Shares
Institutional Equity
Market Cap
N/A
TTM Revenue
N/A
Forward P/E
N/M
Beta / 30D Vol
0.63β · 70% Vol
Unified Composite Score
42.5 / 100
HOLD
Tech 38.0
Fund 33.0
Flow 50.0
Mom 11.1
Weinstein Technical Phase
Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 48.1 · SMA20: $38.63 · SMA50: $32.94
TBXU
NYSE Arca
Head-to-Head Winner
Direxion Daily Biotech Top 5 Bull 2X ETF
Institutional Equity
Market Cap
N/A
TTM Revenue
N/A
Forward P/E
N/M
Beta / 30D Vol
0.74β · 47% Vol
Unified Composite Score
48.6 / 100
HOLD
Tech 38.0
Fund 43.0
Flow 50.0
Mom 31.1
Weinstein Technical Phase
Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 48.3 · SMA20: $46.02 · SMA50: $41.74
6-Pillar Scorecard Institutional Category Breakdown (ELIL 0 – 0 TBXU)
Columns: Metric · ELIL · TBXU
1. Valuation Multiples
Tie
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
N/M
N/M
2. Growth & Scale
Tie
Revenue Growth (YoY)
N/A
N/A
Earnings Growth (YoY)
N/A
N/A
TTM Revenue (USD)
N/A
N/A
Market Cap
N/A
N/A
3. Profitability & Quality
Tie
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Net Profit Margin
N/A
N/A
Return on Equity (ROE)
N/A
N/A
4. Balance Sheet & Cash Flow
Tie
Cash Generation (TTM)
N/A
N/A
Cash Flow Margin
N/A
N/A
Net Cash / Leverage
N/A ROE
N/A ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
56.2% (<1st %ile)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Neutral
NEUTRAL · Neutral
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Institutional Equity Operator
Institutional Equity Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: ELIL (0) vs TBXU (3)
Institutional Metric
ELIL
TBXU
Criterion
Row Edge
Market Capitalization
Scale
N/A
N/A
Larger Scale
Tie
Trailing P/E Ratio
Valuation
N/M
N/M
Lower Multiple
Tie
Forward P/E Ratio
Valuation
N/M
N/M
Lower Multiple
Tie
Revenue Growth (YoY)
Growth
N/A
N/A
Higher Growth
Tie
Operating Margin (TTM)
Profitability
N/A
N/A
Higher Margin
Tie
Net Profit Margin
Profitability
N/A
N/A
Higher Margin
Tie
Return on Equity (ROE)
Capital Efficiency
N/A
N/A
Higher ROE
Tie
52-Week Range Position
Momentum
74% ($16–$44)
78% ($27–$49)
Stronger Trend
TBXU
Beta / 30D Volatility
Risk Regime
0.63β · 70% Vol
0.74β · 47% Vol
Lower Realized Risk
TBXU
Unified Institutional Score
Composite Signal
42.5 / 100 (HOLD)
48.6 / 100 (HOLD)
Higher Composite
TBXU
Trailing 12M Revenue (USD)
Operating Scale
N/A
N/A
FX-Normalized USD
Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A
N/A
Higher Margin
Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev
N/M PEG · N/M EV/Rev
Lower Multiple
Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE)
N/A (N/A ROE)
Higher Cash / Net Cash
Solvency
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M
3M
6M
1Y
1M Horizon
TBXU +1.46 pp
ELIL:
+4.6%
·
TBXU:
+6.06%
3M Horizon
ELIL +10.57 pp
ELIL:
+11.0%
·
TBXU:
+0.43%
6M Horizon
TBXU +8.26 pp
ELIL:
+44.47%
·
TBXU:
+52.73%
1Y Horizon
TBXU +19.13 pp
ELIL:
+18.6%
·
TBXU:
+37.73%
Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)
Split-Invariant USD Revenue & Operating Margin (%)
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ELIL vs TBXU. Trailing 12-month operating profitability (ELIL N/A vs TBXU N/A) and valuation multiples (ELIL N/M vs TBXU N/M Forward P/E) are benchmarked directly in Pillar 4 below.
ELIL ADR TTM Benchmark
FX-Normalized USD
TTM Revenue N/A
Gross Margin N/A
Op. Margin N/A
ROE / Fwd P/E N/A · N/M
TBXU ADR TTM Benchmark
FX-Normalized USD
TTM Revenue N/A
Gross Margin N/A
Op. Margin N/A
ROE / Fwd P/E N/A · N/M
ELIL
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
56.2%
IV Percentile
<1st %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
TBXU
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
ELIL Moat Profile
Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
TBXU Moat Profile
Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ ELIL vs TBXU Key Questions & Quantitative Answers
Is ELIL or TBXU a better stock to buy right now?
As of Nov 20, 2026, Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is the stronger overall head-to-head candidate over Direxion Daily LLY Bull 2X Shares (ELIL) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ELIL carries a Unified Composite Score of 42.5/100 (HOLD) at $36.41 (N/M Forward P/E, N/A operating margin), whereas TBXU carries 48.6/100 (HOLD) at $44.26 (N/M Forward P/E, N/A operating margin). Technically, ELIL sits in a Neutral phase (RSI 48.1, UNCLASSIFIED options structure) and TBXU sits in a Neutral phase (RSI 48.3, UNCLASSIFIED options structure).
Does ELIL or TBXU have stronger revenue and earnings growth?
ELIL and TBXU split Growth & Scale metrics: ELIL posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with TBXU at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ELIL generates N/A in USD-normalized revenue versus N/A for TBXU. In operating R&D and SG&A reinvestment, ELIL deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TBXU.
Is ELIL or TBXU cheaper on valuation?
ELIL and TBXU trade at balanced relative valuation multiples. ELIL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas TBXU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ELIL (N/A ROE) versus TBXU (N/A ROE) capital efficiency.
How is options market volatility positioned on ELIL vs TBXU?
In options market volatility and institutional positioning, ELIL carries 56.2% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.63β · 70% Vol realized risk). By comparison, TBXU carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.74β · 47% Vol realized risk).
Direxion Daily LLY Bull 2X Shares (ELIL) Research Suite
Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.